ProQR Therapeutics (NASDAQ:PRQR) Receives $8.83 Average PT from Analysts
Shares of ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among […]
Shares of ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among […]
